National Health and Medical Research Strategy - Webinar 2 Survey
Overview
The National Health and Medical Research Strategy (National Strategy) will build on Australia’s strengths in health and medical research and world-leading research capability. It will aim to attract researchers and investors and improve health results in communities.
Ms Rosemary Huxtable AO PSM, Chair of the National Strategy, held the second National Strategy online webinar (Webinar 2) on 7 April 2025. It provided an update on work to date to develop the National Strategy, including:
- consultation feedback
- the Australian Health and Medical Research Workforce Audit
- Community Focus Groups
Ms Huxtable was joined by:
- Ms Natasha Ploenges, Chief Executive Officer (CEO) of the Health and Medical Research Office
- Professor Steve Wesselingh, CEO of the National Health and Medical Research Council.
This survey asks for your feedback on the topics covered in the second webinar.
This is the second survey to help develop the National Strategy. It asks different questions from the first survey, which was for the first webinar in December 2024. The answers from both surveys will help develop the National Strategy.
What happens next
Thank you for sharing your views. These will be taken into account when developing the draft National Health and Medical Research Strategy.
Audiences
- Anyone from any background
Interests
- Aboriginal and Torres Strait Islander health
- Administration
- Aged Care
- Alcohol
- Cancer
- Capability
- Children's health
- Chronic disease
- Communicable diseases
- Dementia
- Dental health
- Disability Workforce Action Plan 2016-18
- Drugs and substance abuse
- e-Health
- Environmental health
- Food standards
- Grants and procurement
- Health and Medical Research
- Health insurance
- Health technology
- Hearing
- Home Care
- Hospitals
- Human health
- Immunisation
- Information Technology
- Learning and development
- Legislation
- Management review
- Medicare
- Mental health
- Non-prescription medicines
- Organ and tissue donation
- Pharmaceutical benefits
- Policy Development
- Prescription drugs
- Preventative health
- Regulatory policy
- Residential Aged Care
- Rural health services
- Short-Term Restorative Care
- Staff audit
- Staff election
- Strategic Policy
- Tobacco
- Women's health
Share
Share on Twitter Share on Facebook